Exeligen Scientific Overview
Latest Deal Type
Out of Business
Exeligen Scientific General Information
Description
Developer of a genome editing technology. The company offers genomic engineering products and services such as clustered regularly inter-spaced short palindromic repeats, CRISPR and Cas-related systems.
Want to dig into this profile?
We’ll help you find what you need
Learn more
Exeligen Scientific Valuation & Funding
| Deal Type |
Date |
Amount |
Raised to Date |
Post-Val |
Status |
Stage |
| 2. Out of Business |
01-Nov-2016 |
|
|
|
Completed |
Out of Business |
| 1. Accelerator/Incubator |
28-Oct-2015 |
|
|
|
Completed |
Startup |
Exeligen Scientific Executive Team (3)
| Name |
Title |
Board Seat |
Contact Info |
| David Aguilar Ph.D |
Co-Founder & Chief Executive Officer |
|
|
| Ferrukh Sheikh |
Co-Founder, Chief Financial Officer & President |
|
|
| Mark Stevens Ph.D |
Co-Founder, President of Research & Development & Chief Scientific Officer |
|
|